Identify the carriers of the virus and their immune status, as early as possible, with or without clinical signs.

DIAGNOSIS OF VIRAL INFECTION: 2 METHODS

To join in the global collective effort to tackle the COVID-19 pandemic, NG Biotech company offers rapid tests intended to screen for and monitor the immune status of people potentially infected by the virus.

NG Biotech is a family company specialised in rapid, mobile, and connected bioassays. The company designs and manufactures innovative solutions to meet different needs: response to medical emergency, needs in laboratories, and near-patient needs. Since its creation in 2012, in just a few years, NG Biotech has managed to establish itself and gain notoriety in various areas, especially in the bacteriology field with rapid detection of antibiotic-resistant bacteria, as well as in the field of women’s health with pregnancy tests from one drop of blood. Those tests are available in more than 50 countries, included in the United States.

Established in Brittany (France), NG Biotech has a complete structure with a R&D laboratory, and two production facilities complying with international quality standards.
NG Biotech company positions itself above all to provide support and expertise to various major public health issues.